| Year |
Citation |
Score |
| 2020 |
Hollósi P, Váncza L, Karászi K, Dobos K, Péterfia B, Tátrai E, Tátrai P, Szarvas T, Paku S, Szilák L, Kovalszky I. Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1. Biomolecules. 10. PMID 32977498 DOI: 10.3390/biom10101356 |
0.699 |
|
| 2020 |
Fullár A, Karászi K, Hollósi P, Lendvai G, Oláh L, Reszegi A, Papp Z, Sobel G, Dudás J, Kovalszky I. Two ways of epigenetic silencing of TFPI2 in cervical cancer. Plos One. 15: e0234873. PMID 32559232 DOI: 10.1371/Journal.Pone.0234873 |
0.582 |
|
| 2020 |
Galamb O, Kalmár A, Sebestyén A, Dankó T, Kriston C, Fűri I, Hollósi P, Csabai I, Wichmann B, Krenács T, Barták BK, Nagy ZB, Zsigrai S, Barna G, Tulassay Z, et al. Promoter Hypomethylation and Increased Expression of the Long Non-coding RNA LINC00152 Support Colorectal Carcinogenesis. Pathology Oncology Research : Por. PMID 32307642 DOI: 10.1007/S12253-020-00800-8 |
0.5 |
|
| 2017 |
Péterfia B, Kalmár A, Patai ÁV, Csabai I, Bodor A, Micsik T, Wichmann B, Egedi K, Hollósi P, Kovalszky I, Tulassay Z, Molnár B. Construction of a multiplex mutation hot spot PCR panel: the first step towards colorectal cancer genotyping on the GS Junior platform. Journal of Cancer. 8: 162-173. PMID 28243320 DOI: 10.7150/Jca.16037 |
0.571 |
|
| 2016 |
Módos O, Reis H, Niedworok C, Rübben H, Szendröi A, Szász MA, Tímár J, Baghy K, Kovalszky I, Golabek T, Chlosta P, Okon K, Peyronnet B, Mathieu R, Shariat SF, et al. Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma - occurence and prognostic significance. Oncotarget. PMID 27283768 DOI: 10.18632/Oncotarget.9828 |
0.642 |
|
| 2015 |
Kalmár A, Péterfia B, Hollósi P, Galamb O, Spisák S, Wichmann B, Bodor A, Tóth K, Patai ÁV, Valcz G, Nagy ZB, Kubák V, Tulassay Z, Kovalszky I, Molnár B. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer. Bmc Cancer. 15: 736. PMID 26482433 DOI: 10.1186/S12885-015-1687-X |
0.614 |
|
| 2015 |
Patai ÁV, Valcz G, Hollósi P, Kalmár A, Péterfia B, Patai Á, Wichmann B, Spisák S, Barták BK, Leiszter K, Tóth K, Sipos F, Kovalszky I, Péter Z, Miheller P, et al. Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas. Plos One. 10: e0133836. PMID 26291085 DOI: 10.1371/Journal.Pone.0133836 |
0.608 |
|
| 2015 |
Fullár A, Dudás J, Oláh L, Hollósi P, Papp Z, Sobel G, Karászi K, Paku S, Baghy K, Kovalszky I. Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. Bmc Cancer. 15: 256. PMID 25885552 DOI: 10.1186/S12885-015-1272-3 |
0.593 |
|
| 2014 |
Molnar B, Peterfia B, Kalmar A, Hollosi P, Nagy ZB, Wichmann B, Kovalszky I, Tulassay Z. Abstract 422: DNA hypermethylation or upregulated miRNA21 expression potentially leads to decreased mRNA expression of COL1A2, SFRP2, SOCS3, BCL2, MAL and PTGS2 in left-sided colorectal adenoma and cancer Cancer Research. 74: 422-422. DOI: 10.1158/1538-7445.Am2014-422 |
0.613 |
|
| 2013 |
Sipos F, M?zes G, Patai AV, F?ri I, Péterfia B, Hollósi P, Molnár B, Tulassay Z. Genome-wide screening for understanding the role of DNA methylation in colorectal cancer. Epigenomics. 5: 569-81. PMID 24059802 DOI: 10.2217/Epi.13.52 |
0.354 |
|
| 2013 |
Patai AV, Kalmar A, Galamb O, Valcz G, Patai A, Peterfia B, Hollosi P, Wichmann B, Leiszter K, Tóth K, Schöller A, Spisak S, Sipos F, Tulassay Z, Molnar B. Abstract 5361: Characteristic DNA methylation signature in sporadic colorectal cancer and in premalignant lesions. Cancer Research. 73: 5361-5361. DOI: 10.1158/1538-7445.Am2013-5361 |
0.395 |
|
| 2013 |
Kalmár A, Peterfia B, Hollosi P, Galamb O, Spisak S, Wichmann B, Tóth K, Leiszter K, Patai ÁV, Kubak V, Kiss K, Horvath Z, Valcz G, Tulassay Z, Kovalszky I, et al. Su1998 Gene Expression-Based High-Throughput Screening Reveals COL12, PTGDR, SFRP2 and SOCS3 As Potential Novel Methylation Markers of Left-Sided Colorectal Cancer Gastroenterology. 144: S-527. DOI: 10.1016/S0016-5085(13)61960-5 |
0.579 |
|
| 2012 |
Péterfia B, Füle T, Baghy K, Szabadkai K, Fullár A, Dobos K, Zong F, Dobra K, Hollósi P, Jeney A, Paku S, Kovalszky I. Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2. Plos One. 7: e39474. PMID 22745764 DOI: 10.1371/Journal.Pone.0039474 |
0.698 |
|
| 2009 |
Zong F, Fthenou E, Wolmer N, Hollósi P, Kovalszky I, Szilák L, Mogler C, Nilsonne G, Tzanakakis G, Dobra K. Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells. Plos One. 4: e7346. PMID 19802384 DOI: 10.1371/Journal.Pone.0007346 |
0.545 |
|
| 2009 |
Hollosi P, Yakushiji JK, Fong KS, Csiszar K, Fong SF. Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells. International Journal of Cancer. 125: 318-27. PMID 19330836 DOI: 10.1002/Ijc.24308 |
0.316 |
|
| 2007 |
Fong SF, Dietzsch E, Fong KS, Hollosi P, Asuncion L, He Q, Parker MI, Csiszar K. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors. Genes, Chromosomes & Cancer. 46: 644-55. PMID 17394133 DOI: 10.1002/Gcc.20444 |
0.432 |
|
| 2006 |
Péterfia B, Hollósi P, Szilák L, Timár F, Paku S, Jeney A, Kovalszky I. [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma]. Magyar Onkologia. 50: 115-20. PMID 16888674 |
0.61 |
|
| 2004 |
Kovalszky I, Dudás J, Gallai M, Hollósi P, Tátrai P, Tátrai E, Schaff Z. [Proteoglycans in the liver]. Magyar Onkologia. 48: 207-13. PMID 15520870 |
0.685 |
|
| Show low-probability matches. |